Performance of digital morphology analyzer CellaVision DC-1.

Area of Science:

• Hematology
• Laboratory Medicine
• Medical Technology

Background:

• Digital morphology analyzers are increasingly used in clinical laboratories.
• The CellaVision DC-1 is a new system designed for small to medium-volume laboratories.
• Comprehensive performance evaluation is crucial for adopting new diagnostic tools.

Purpose of the Study:

• To evaluate the precision, qualitative performance, cell counting accuracy, and turnaround time (TAT) of the CellaVision DC-1.
• To assess the suitability of the DC-1 for peripheral blood smear (PBS) review in resource-limited settings.

Main Methods:

• Performance was assessed using peripheral blood smear slides according to CLSI guidelines (EP15-A3, EP15-Ed3-IG1, EP12-A2).
• Cell counts from DC-1 were compared against manual counting using CLSI guideline EP 09C-ED3.
• Turnaround time (TAT) for DC-1 was compared with manual slide review.

Main Results:

• DC-1 exhibited excellent precision (%CV: 0.0-3.5%) and high specificity (98.9-100.0%) across 18 cell classes.
• High negative predictive value (98.4-100.0%) was observed.
• However, zero positive predictive value was noted for seven specific cell types, including blasts and nucleated red blood cells.
• The largest absolute mean difference between DC-1 and manual counts was 2.74%.
• Total TAT was comparable: 8:55 for DC-1 and 8:55 for manual counting.

Conclusions:

• The CellaVision DC-1 shows reliable performance for assisting peripheral blood smear review in small to medium-volume labs.
• Its precision and specificity support its use, but limitations exist for certain cell classes.
• The system may generate additional workload for verification of specific cell types, requiring careful workflow integration.